Migdal Insurance & Financial Holdings Ltd. Guardant Health, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$109.77 - $165.68 $610,101 - $920,849	-5,558 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$127.04 - $179.1 $438,160 - $617,715	3,449 Added 163.54%	5,558 $848,000
Q4 2020 Feb 08, 2021	BUY	$99.96 - $135.93 $210,815 - $286,676	2,109 New	2,109 $272,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$369 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$355 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$320 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$219 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$189 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account